Maze Therapeutics, Inc. (MAZE) on GreekSoup https://greeksoup.ai/stocks/us/maze/ Every dated entry in the public record on Maze Therapeutics, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 28 Oct 2026 00:00:00 +0000 Maze Therapeutics, Inc. filed 8-K: material agreement, unregistered sale of equityhttps://greeksoup.ai/stocks/us/maze/filings/us:MAZE:filing:2026-10-16:b00aed7adbFri, 16 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: short interest 7,527,939 shares at the 15 October 2026 settlement, 10.09 days to coverhttps://greeksoup.ai/stocks/us/maze/short-interest/us:MAZE:short-interest:2026-10-15:dc8272a807Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Coloma Jason V (Chief Executive Officer), the Coloma 2021 Irrevocable Trust, sold 2,593 shares (under a trading plan set in advance) at $27.02 on 1 October 2026, $70,073https://greeksoup.ai/stocks/us/maze/insiders/us:MAZE:insider:2026-10-02:5f48c0d7a0Fri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Coloma Jason V (Chief Executive Officer), coloma Family Trust, sold 31,908 shares (under a trading plan set in advance) at $27.02 on 1 October 2026, $862,186https://greeksoup.ai/stocks/us/maze/insiders/us:MAZE:insider:2026-10-02:774fbb93edFri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Bernstein Harold (President, R&D & CMO) sold 16,141 shares (under a trading plan set in advance) at $26.93 on 1 October 2026, $434,743https://greeksoup.ai/stocks/us/maze/insiders/us:MAZE:insider:2026-10-02:74742ad01dFri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Form 144, HAROLD BERNSTEIN plans to sell 16,141 shares worth $438,712 around 1 October 2026https://greeksoup.ai/stocks/us/maze/planned-sales/us:MAZE:planned-sale:2026-10-01:8d305ae6b6Thu, 01 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Form 144, Coloma Jason V plans to sell 34,501 shares worth $933,252 around 1 October 2026https://greeksoup.ai/stocks/us/maze/planned-sales/us:MAZE:planned-sale:2026-10-01:32b5d81f6aThu, 01 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Dandekar Atul (CSBO) sold 7,500 shares (under a trading plan set in advance) at $27.06 on 29 September 2026, $202,921https://greeksoup.ai/stocks/us/maze/insiders/us:MAZE:insider:2026-10-01:6a8caddeaeThu, 01 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: short interest 6,565,330 shares at the 30 September 2026 settlement, 6.07 days to coverhttps://greeksoup.ai/stocks/us/maze/short-interest/us:MAZE:short-interest:2026-09-30:036bc6611aWed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: short interest 5,678,289 shares at the 15 September 2026 settlement, 10.40 days to coverhttps://greeksoup.ai/stocks/us/maze/short-interest/us:MAZE:short-interest:2026-09-15:db8ae6607eTue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Bernstein Harold (President, R&D & CMO) sold 9,705 shares (under a trading plan set in advance) at $26.22 on 4 September 2026, $254,502https://greeksoup.ai/stocks/us/maze/insiders/us:MAZE:insider:2026-09-08:3175722c7fTue, 08 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Form 144, HAROLD BERNSTEIN plans to sell 9,705 shares worth $251,068 around 4 September 2026https://greeksoup.ai/stocks/us/maze/planned-sales/us:MAZE:planned-sale:2026-09-04:3f1f32bf3eFri, 04 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Courtney Phillips (GC and Corp. Secretary) sold 1,990 shares at $26.01 on 3 September 2026, $51,766https://greeksoup.ai/stocks/us/maze/insiders/us:MAZE:insider:2026-09-04:bcdf0309abFri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Courtney Phillips (GC and Corp. Secretary) sold 22 shares at $25.78 on 3 September 2026, $567https://greeksoup.ai/stocks/us/maze/insiders/us:MAZE:insider:2026-09-04:d0328b0fdfFri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Dandekar Atul (CSBO) sold 3,207 shares at $26.01 on 3 September 2026, $83,425https://greeksoup.ai/stocks/us/maze/insiders/us:MAZE:insider:2026-09-04:465934ac33Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Dandekar Atul (CSBO) sold 36 shares at $25.81 on 3 September 2026, $929https://greeksoup.ai/stocks/us/maze/insiders/us:MAZE:insider:2026-09-04:fa290301f7Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Coloma Jason V (Chief Executive Officer) sold 11,282 shares at $26.01 on 3 September 2026, $293,482https://greeksoup.ai/stocks/us/maze/insiders/us:MAZE:insider:2026-09-04:91b768f5cdFri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Coloma Jason V (Chief Executive Officer) sold 129 shares at $25.77 on 3 September 2026, $3,325https://greeksoup.ai/stocks/us/maze/insiders/us:MAZE:insider:2026-09-04:9518fa9f7fFri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Bernstein Harold (President, R&D & CMO) sold 5,130 shares at $26.01 on 3 September 2026, $133,448https://greeksoup.ai/stocks/us/maze/insiders/us:MAZE:insider:2026-09-04:291f1ba4f8Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Bernstein Harold (President, R&D & CMO) sold 59 shares at $25.78 on 3 September 2026, $1,521https://greeksoup.ai/stocks/us/maze/insiders/us:MAZE:insider:2026-09-04:237a6e3a77Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Courtney Phillips (GC and Corp. Secretary) sold 1,738 shares at $26.38 on 2 September 2026, $45,841https://greeksoup.ai/stocks/us/maze/insiders/us:MAZE:insider:2026-09-04:14d968430bFri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Courtney Phillips (GC and Corp. Secretary) sold 243 shares at $27.12 on 2 September 2026, $6,590https://greeksoup.ai/stocks/us/maze/insiders/us:MAZE:insider:2026-09-04:ae2f9d5935Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Dandekar Atul (CSBO) sold 2,800 shares at $26.38 on 2 September 2026, $73,853https://greeksoup.ai/stocks/us/maze/insiders/us:MAZE:insider:2026-09-04:867072e560Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Dandekar Atul (CSBO) sold 391 shares at $27.12 on 2 September 2026, $10,604https://greeksoup.ai/stocks/us/maze/insiders/us:MAZE:insider:2026-09-04:b4fbcea364Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Coloma Jason V (Chief Executive Officer) sold 9,852 shares at $26.38 on 2 September 2026, $259,856https://greeksoup.ai/stocks/us/maze/insiders/us:MAZE:insider:2026-09-04:7b33e9f44cFri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Coloma Jason V (Chief Executive Officer) sold 1,375 shares at $27.12 on 2 September 2026, $37,292https://greeksoup.ai/stocks/us/maze/insiders/us:MAZE:insider:2026-09-04:4ea5624cd5Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Bernstein Harold (President, R&D & CMO) sold 4,481 shares at $26.38 on 2 September 2026, $118,191https://greeksoup.ai/stocks/us/maze/insiders/us:MAZE:insider:2026-09-04:4edf538b44Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Bernstein Harold (President, R&D & CMO) sold 625 shares at $27.12 on 2 September 2026, $16,951https://greeksoup.ai/stocks/us/maze/insiders/us:MAZE:insider:2026-09-04:ac06550d8cFri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Coloma Jason V (Chief Executive Officer), the Coloma 2021 Irrevocable Trust, sold 2,593 shares (under a trading plan set in advance) at $26.31 on 1 September 2026, $68,214https://greeksoup.ai/stocks/us/maze/insiders/us:MAZE:insider:2026-09-03:e0f835d29fThu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Coloma Jason V (Chief Executive Officer), coloma Family Trust, sold 31,908 shares (under a trading plan set in advance) at $26.29 on 1 September 2026, $838,785https://greeksoup.ai/stocks/us/maze/insiders/us:MAZE:insider:2026-09-03:6d87ec7575Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Bernstein Harold (President, R&D & CMO) sold 16,141 shares (under a trading plan set in advance) at $26.36 on 1 September 2026, $425,512https://greeksoup.ai/stocks/us/maze/insiders/us:MAZE:insider:2026-09-03:836bf50ea8Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Form 144, Courtney Phillips plans to sell 4,144 shares worth $110,000 around 2 September 2026https://greeksoup.ai/stocks/us/maze/planned-sales/us:MAZE:planned-sale:2026-09-02:c90c732016Wed, 02 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Form 144, Atul Dandekar plans to sell 6,679 shares worth $177,200 around 2 September 2026https://greeksoup.ai/stocks/us/maze/planned-sales/us:MAZE:planned-sale:2026-09-02:4fabada061Wed, 02 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Form 144, Harold Bernstein plans to sell 10,685 shares worth $283,500 around 2 September 2026https://greeksoup.ai/stocks/us/maze/planned-sales/us:MAZE:planned-sale:2026-09-02:fae12097a9Wed, 02 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Form 144, Jason V Coloma plans to sell 23,497 shares worth $623,400 around 2 September 2026https://greeksoup.ai/stocks/us/maze/planned-sales/us:MAZE:planned-sale:2026-09-02:649a4f325eWed, 02 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Form 144, Coloma Jason V plans to sell 34,501 shares worth $908,066 around 1 September 2026https://greeksoup.ai/stocks/us/maze/planned-sales/us:MAZE:planned-sale:2026-09-01:b9ae74288bTue, 01 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Dandekar Atul (CSBO) sold 7,500 shares (under a trading plan set in advance) at $27.58 on 28 August 2026, $206,824https://greeksoup.ai/stocks/us/maze/insiders/us:MAZE:insider:2026-08-31:0a876eb731Mon, 31 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: short interest 5,918,321 shares at the 31 August 2026 settlement, 16.05 days to coverhttps://greeksoup.ai/stocks/us/maze/short-interest/us:MAZE:short-interest:2026-08-31:73ec3664c7Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc. filed 8-K: officer or director change, regulation fd disclosurehttps://greeksoup.ai/stocks/us/maze/filings/us:MAZE:filing:2026-08-17:7ed440a1b8Mon, 17 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Schedule 13G/A filed by Paradigm BioCapital Advisors LP, 0.0% of the classhttps://greeksoup.ai/stocks/us/maze/holders/us:MAZE:schedule-13:2026-08-14:38deb20baeFri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Bernstein Harold (President, R&D & CMO) sold 16,142 shares (under a trading plan set in advance) at $27.61 on 13 August 2026, $445,621https://greeksoup.ai/stocks/us/maze/insiders/us:MAZE:insider:2026-08-14:a124c5b865Fri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: short interest 5,988,933 shares at the 14 August 2026 settlement, 16.17 days to coverhttps://greeksoup.ai/stocks/us/maze/short-interest/us:MAZE:short-interest:2026-08-14:7a55251989Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc. Q2 FY2026 results: revenue $0, net income -$45 millionhttps://greeksoup.ai/stocks/us/maze/results/fy2026-q2/us:MAZE:result:2026-08-11:61d8501a13Tue, 11 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/maze/filings/us:MAZE:filing:2026-08-11:37682eb11aTue, 11 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/maze/filings/us:MAZE:filing:2026-08-11:34be706ac0Tue, 11 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Coloma Jason V (Chief Executive Officer), the Coloma 2021 Irrevocable Trust, sold 2,439 shares (under a trading plan set in advance) at $26.71 on 3 August 2026, $65,157https://greeksoup.ai/stocks/us/maze/insiders/us:MAZE:insider:2026-08-05:5892af6da8Wed, 05 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Coloma Jason V (Chief Executive Officer), the Coloma 2021 Irrevocable Trust, sold 154 shares (under a trading plan set in advance) at $27.09 on 3 August 2026, $4,172https://greeksoup.ai/stocks/us/maze/insiders/us:MAZE:insider:2026-08-05:c3e531ecc6Wed, 05 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Coloma Jason V (Chief Executive Officer), coloma Family Trust, sold 30,304 shares (under a trading plan set in advance) at $26.71 on 3 August 2026, $809,541https://greeksoup.ai/stocks/us/maze/insiders/us:MAZE:insider:2026-08-05:546f246e14Wed, 05 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Coloma Jason V (Chief Executive Officer), coloma Family Trust, sold 1,604 shares (under a trading plan set in advance) at $27.09 on 3 August 2026, $43,445https://greeksoup.ai/stocks/us/maze/insiders/us:MAZE:insider:2026-08-05:24ccbd7587Wed, 05 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Form 144, Coloma Jason V plans to sell 34,501 shares worth $922,557 around 3 August 2026https://greeksoup.ai/stocks/us/maze/planned-sales/us:MAZE:planned-sale:2026-08-03:44db51d3c4Mon, 03 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Dandekar Atul (CSBO) sold 7,100 shares (under a trading plan set in advance) at $27.31 on 29 July 2026, $193,875https://greeksoup.ai/stocks/us/maze/insiders/us:MAZE:insider:2026-07-31:b10bf47094Fri, 31 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: Dandekar Atul (CSBO) sold 400 shares (under a trading plan set in advance) at $27.89 on 29 July 2026, $11,156https://greeksoup.ai/stocks/us/maze/insiders/us:MAZE:insider:2026-07-31:50e5a77f4cFri, 31 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Maze Therapeutics, Inc.: short interest 5,678,545 shares at the 31 July 2026 settlement, 15.88 days to coverhttps://greeksoup.ai/stocks/us/maze/short-interest/us:MAZE:short-interest:2026-07-31:dd80dd1c1bFri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>